dihexa human clinical trials trial status Dihexa shows neurotrophic activity exceeding BDNF in preclinical studies DIHEXA | Peptide Synthetic dihexa clinical trial human studies

View on PubMed Involvement of the AT1 Receptor in Effects of Angiotensin IV and LVV-Haemorphin 7 on Hippocampal Memory Demonstrated that angiotensin IV analogs (the parent class of Dihexa) improve hippocampal memory performance in rodents, supporting the AT4/IRAP receptor pathway as a target for cognitive enhancement (J Neurochem, 2010)

The interaction between vitamin C and peptides is relevant for skin health, as is the combination of peptides and retinol for those using retinoids

Practically, it is why titration schedules exist

It is not approved for human or animal use and must not be incorporated into food, drugs, cosmetics, or diagnostic products

This multi-pronged approach may be especially beneficial for patients who have not achieved satisfactory results with single-agent therapies